###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
C4B null alleles are not associated with genetic polymorphisms in the adjacent gene CYP21A2 in autism
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 429 437 429 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 550 554 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 578 586 578 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
Research indicates that the etiology of autism has a strong genetic component, yet so far the search for genes that contribute to the disorder, including several whole genome scans, has led to few consistent findings. However, three studies indicate that the complement C4B gene null allele (i.e. the missing or nonfunctional C4B gene) is significantly more frequent in individuals with autism. Due to the close proximity of the CYP21A2 gene to the C4B locus (3 kb) it was decided to examine samples from autistic subjects, including many with known C4B null alleles for common CYP21A2 mutations.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 233 241 233 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 343 351 343 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
Samples from subjects diagnosed with autism and non-autistic controls (controls) previously typed for C4B null alleles were studied. Allele specific polymerase chain reaction (PCR) methods were used to determine 8 of the most common CYP21A2 genetic mutations, known to completely or partially inhibit 21-hydroxylase, the enzyme encoded by the CYP21A2 gene.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 238 246 238 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 396 404 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
Although the combined autism and control study subjects had 50 C4B null alleles only 15 CYP21A2 mutations were detected in over 2250 genotypes. Eight mutations were detected in the autistic samples and 7 in the controls. The frequency of CYP21A2 mutations was similar between the autism and control samples. Only one individual (autistic) carried a chromosome containing both C4B null allele and CYP21A2 mutations.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 181 189 <span type="species:ncbi:9606">children</span>
Autism is a severe neurodevelopmental disorder that is approximately four times more common in males than females. The current prevalence for the disorder is approximately 1 in 152 children [1]. Although there are various mechanisms that can lead to this behaviorally defined condition, in most cases the etiology remains unknown. A strong genetic component clearly exists [2]; however, consistent detection of disease associated genetic variants has rarely been reported. Whole genome scans using microarray technology may better detect the genetic contributions to autism susceptibility [3].
###end p 9
###begin p 10
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 179 192 179 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RP, C4, CYP21</italic>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNX </italic>
###xml 325 329 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RP1 </italic>
###xml 332 341 332 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RP2, C4A </italic>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 365 373 365 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 376 384 376 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A1P</italic>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNXA </italic>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNXB</italic>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RP2 </italic>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNXA </italic>
###xml 442 451 442 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A1P </italic>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Genes located in the RCCX module found on chromosome 6 in the human leukocyte antigen (HLA) locus are associated with various disease states [4,5]. This module contains the genes RP, C4, CYP21, and TNX (abbreviated RCCX) in a contiguous sequence. Different variants of these four genes can exist in the RCCX module including RP1 or RP2, C4A or C4B (long or short), CYP21A2 or CYP21A1P, and TNXA or TNXB. RP2 and TNXA are gene fragments while CYP21A1P is a pseudogene. A single chromosome usually contains one, two, three RCCX modules in tandem, but rare cases can have four modules.
###end p 10
###begin p 11
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4A </italic>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4 </italic>
###xml 384 387 384 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4 </italic>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 450 455 <span type="species:ncbi:9606">human</span>
Because of the diversity in the number and size of the RCCX modules misalignments and unequal crossovers occur during meiosis resulting frequently in deletions, conversions, duplications along with the acquisition of mutations from nearby pseudogenes or gene segments [6]. One such mutation in this module is the missing/nonfunctional C4A or C4B gene (C4 null allele). Therefore, the C4 containing complex is an extraordinarily complex region of the human genome [7] (Figure 1).
###end p 11
###begin p 12
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Three common arrangements of the RCCX module</bold>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4 </italic>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4A </italic>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 296 306 296 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HERV-K(C4)</italic>
###xml 347 356 347 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A1* </italic>
###xml 375 384 375 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A1P </italic>
###xml 402 410 402 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 674 678 674 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 783 787 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 803 811 803 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 296 302 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
Three common arrangements of the RCCX module. Monomodular, bimodular, and trimodular are present in about 17, 69 and 14% of chromosomes, respectively [7]. The C4 gene which is either C4A or C4B can be either a long or short variant depending upon the presence of a 6.36 kb endogenous retrovirus, HERV-K(C4). Pseudogenes or gene fragments are red. CYP21A1* indicates either a CYP21A1P pseudogene or the CYP21A2 gene. In the present study 40 chromosomes from autistic individuals had a C4B null allele. Of these chromosomes 19 were monomodular and 21 were bimodular. In the control subjects with C4B null alleles 10 chromosomes were monomodular and 1 was bimodular. Bimodular C4B null alleles were significantly more frequent in autistic subjects compared to controls (P = 0.0001). No C4B null alleles or CYP21A2 mutations were detected in the subjects (2 autistic, 4 control) with trimodular RCCX modules, determined by protein immunofixation electrophoresis [10].
###end p 12
###begin p 13
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 325 333 325 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 382 385 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4 </italic>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 441 449 441 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 622 630 622 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 675 683 675 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
The RCCX module may play a significant role in the genetic underpinnings of autism. Several studies have shown that the frequency of C4B null alleles is increased in individuals with autism [8-10], the most recent of which found that 42.4% of autistic subjects carry a C4B null allele compared to 14.5% of controls [10]. The CYP21A2 gene is located approximately 3 kb downstream of C4 and the concurrent deletion of C4B with portions of the CYP21A2 has been described [11,12]. Therefore, the aim of the present research was to determine if the C4B null allele, found frequently in subjects with autism, is associated with CYP21A2 mutations. As well, the overall frequency of CYP21A2 mutations in autistic verses control subjects was determined.
###end p 13
###begin p 14
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4 </italic>
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
C4 genes encode innate immune C4 proteins that are important in the complement cascade. CYP21A2 encodes an enzyme, 21-hydroxylase, which is important in the synthesis of cortisol and in maintaining proper androgen levels.
###end p 14
###begin p 15
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 175 183 175 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 308 316 308 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 421 429 421 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
Over 2,250 genetic typings of CYP21A2 mutations were completed in 80 autistic and 60 controls subjects that had previously been typed for C4B null alleles [10]. Fifteen total CYP21A2 mutations where detected; however, only one individual (autistic) carried a chromosome containing both a C4B null allele and CYP21A2 mutations. Therefore, in these subjects it does not appear that C4B null alleles are associated with the CYP21A2 mutations studied.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Subjects
###end title 17
###begin p 18
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4A </italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 752 757 <span type="species:ncbi:9606">child</span>
This study utilized samples previously characterize for C4A and C4B null alleles in an autism case-control study [10]. Autistic subjects and controls were Caucasian of Northern European descent and IRB (Utah State University) approval was obtained for this study. As reported, the subjects were diagnosed with autism using DSM-IV criteria by pediatric psychiatrists and psychologists expert in the evaluation of autism. The Autism Diagnostic Observation Schedule (ADOS) [13] and the Autism Diagnostic Inventory (ADI) [14] confirmed the Diagnosis. Various CYP21A2 genetic determinations were completed in 80 individuals with autism (8 female, 72 male) and 60 control subjects (15 female, 45 male). Parents of the particular subjects were typed if their child was positive for a mutation.
###end p 18
###begin title 19
DNA preparation
###end title 19
###begin p 20
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 348 351 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
DNA samples were extracted from peripheral blood mononuclear cells as previously described [15]. To genotype samples with limited amounts of DNA, whole genome amplification was performed using multiple displacement amplification (MDA) based on the method of Dean et al.[16]. MDA was performed using RepliPHItrade mark Phi 29 Reagent Sets (Epicentre(R)Technologies, Madison, Wisconsin).
###end p 20
###begin p 21
###xml 9 13 9 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 244 247 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
PicoGreen(R) quantitation of amplified DNA was performed using a Quant-iTtrade mark DNA Assay Kit from Molecular Probestrade mark (Eugene, Oregon) according to kit protocol. Fluorescence was measured with a Synergy HT microplate reader (BIO-TEK(R), Winooski, Vermont).
###end p 21
###begin title 22
Polymerase chain reaction
###end title 22
###begin p 23
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 251 259 251 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 681 689 681 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 806 810 806 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 814 822 814 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 880 886 880 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
Seven mutations were determined by allele-specific polymerase chain reaction (PCR) based on the method of Wilson et al.[17]. This method is as accurate as the dot blot procedure [17]; therefore, it is sensitive enough to detect a mutation in only one CYP21A2 gene if more than two copies of the gene are present. The mutations analyzed included amino acid substitutions (P30L, I172N, V281L, R356W, exon 6 cluster mutation (L236N, V237Q, M239K)), a splicing mutation (intron 2 (656) A/C to G), and a deletion (exon 3, 8 base pair deletion). Each reaction contained a primer specific for either the common or rare genetic variant in conjunction with a primer that amplified only the CYP21A2 gene and not the pseudogene (Table 1). A PCR based assay for detection of a 30 kb deletion/conversion affecting both C4B and CYP21A2 was performed based upon the method described in Keen-Kim et al.[18].
###end p 23
###begin p 24
Sequences of oligonucleotide primers for allele-specific PCR
###end p 24
###begin title 25
Statistics
###end title 25
###begin p 26
Chi-square analysis along with the Fisher's Exact Test where performed using SPSS 14 (SPSS Inc., Chicago, Illinois). A two-tailed test with a P-value of < 0.05 was considered significant after Bonferoni corrections for multiple comparisons.
###end p 26
###begin title 27
Results and discussion
###end title 27
###begin p 28
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 138 146 138 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 200 208 200 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 376 384 376 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 464 472 464 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
Although the 80 autistic individuals studied had 40 C4B null alleles and the 60 control individuals had 10 C4B null alleles only 15 total CYP21A2 mutations were detected in over 2250 genotypes. Eight CYP21A2 mutations were detected in the autistic subjects and 7 in the controls (Table 2). Only one individual (autistic) had a chromosome carrying both a C4B null allele and a CYP21A2 mutation. Therefore, no association was determined between C4B null alleles and CYP21A2 mutations in the study subjects.
###end p 28
###begin p 29
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
Frequencies of the C4B null allele and CYP21A2 mutations
###end p 29
###begin p 30
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 159 167 159 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 195 203 195 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 378 386 378 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 638 643 <span type="species:ncbi:9606">child</span>
###xml 785 793 <span type="species:ncbi:9606">children</span>
Overall, the number of CYP21A2 mutations did not differ between the autism and control groups and no group differences were found in frequencies of individual CYP21A2 mutations. The frequency of CYP21A2 mutations seen in this research is similar to general population frequencies reported by others [19]. Five individuals with autism (6.25%) and five controls (8.33%) carried a CYP21A2 mutation. Two individuals with autism and one control subject carried two or three mutations. In these cases the mutations all typed to individual parents. Thus, the multiple mutations were found on single chromosomes. When a mutation was found in the child's DNA it was also present in DNA from one of the parents, thus confirming both accurate typing and absence of de novo mutations in the study children.
###end p 30
###begin p 31
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 267 270 267 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4A</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4A</italic>
###xml 347 350 347 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4A</italic>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 372 380 372 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
HLA extended haplotyes known to contain C4B null alleles are increased in frequency in autistic individuals (i.e. HLA extended haplotypes 35.2 (n = 4), 35.3 (n = 2), 44.1 (n = 8), and 58.1 (n = 1)). Extended haplotypes 35.3 and 58.1 have monomodular RCCX structures (C4A: C4B null allele) and extended haplotypes 35.2 and 44.1 are bimodular (C4A, C4A:C4B null allele). No CYP21A2 mutations were observed in these haplotypes.
###end p 31
###begin p 32
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4A </italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4A </italic>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B</italic>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
The HLA 8.1 is present in 10% of the Caucasian population and represents the most common extended haplotype. It has a monomodular RCCX structure with a C4A null allele and a normal C4B gene (C4A null allele: C4B). This extended haplotype, referred to as COX in the MHC Haplotype Project [20], has been completely sequenced [21]. Of the eighteen subjects with an 8.1 extended haplotype one had the rare SNP creating the TTG codon that encodes for leucine at position 281 while 17 subjects had the common codon GTG that encodes for valine at position 281. This observation is in agreement with DNA sequencing data that shows low level SNP diversity in 8.1 extended haplotypes from different individuals [22].
###end p 32
###begin p 33
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 247 255 247 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 276 293 276 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A1P/CYP21A2 </italic>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 439 447 439 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
The specific CYP21A2 mutations were chosen because they are the most common mutations that result in significant decreases in 21-hydroxylase activity. One of the mutations investigated was a 30 kb deletion/conversion that deletes C4B and converts CYP21A2 into a nonfunctional CYP21A1P/CYP21A2 hybrid with its pseudogene (Figure 2). This mutation was of particular interest because it provides a direct link between a C4B null allele and a CYP21A2 mutation. One autistic subject and two controls carried this mutation. Again, these three polymorphisms were inherited and did not involve de novo mutations.
###end p 33
###begin p 34
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2</italic>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The 30 kb deletion/conversion of <italic>C4B </italic>and <italic>CYP21A2</italic></bold>
###xml 106 119 106 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RP, C4, CYP21</italic>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNX </italic>
###xml 223 248 223 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A1P, TNXA, RP2, C4B </italic>
###xml 260 268 260 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 299 316 299 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A1P/CYP21A2 </italic>
The 30 kb deletion/conversion of C4B and CYP21A2. This diagram depicts the most common arrangement of the RP, C4, CYP21, and TNX (RCCX) gene module. Pseudogenes or gene fragments are red. The 30 kb deletion removes part of CYP21A1P, TNXA, RP2, C4B and part of CYP21A2 leaving a non-protein encoding CYP21A1P/CYP21A2 region.
###end p 34
###begin p 35
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
It has been reported that two of the mutations, P30L and V281L, partially inhibit 21-hydroxylase activity (30-60% of normal), whereas the other mutations analyzed cause either complete or nearly complete enzyme inhibition [23]. Four subjects with autism (5%) carried a partially inhibiting mutation (P30L or V281L) compared to two control subjects (3.33%). This difference is not statistically significant.
###end p 35
###begin p 36
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
21-hydroxylase deficiency is the most common cause of congenital adrenal hyperplasia. Some evidence supports the idea of 21-hydroxylase being involved in autism [24], which could result in the excessive androgen production seen in some cases [25] and thereby contribute to disease etiology [26,27]. The present data does not provide genetic support for 21-hydroxylase involvement in autism.
###end p 36
###begin title 37
Conclusion
###end title 37
###begin p 38
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 126 134 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 204 212 204 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 271 279 271 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C4B </italic>
###xml 395 403 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 451 459 451 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 552 560 552 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 617 625 617 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP21A2 </italic>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
This study examined both mono and bimodular RCCX genetic modules that contain C4B null alleles for mutations in the adjoining CYP21A2 gene. The C4B null alleles seen in autism are not associated with the CYP21A2 genetic mutations examined in this study. The frequency of CYP21A2 mutations was similar between the autism and control groups. Based on family typings no de novo mutations of C4B or CYP21A2 were apparent in study subjects. Therefore, the CYP21A2 mutations studied do not appear to contribute to the etiology of autism. However, a role for CYP21A2 in autism cannot be ruled out as other factors affecting CYP21A2 gene expression such as promoter polymorphisms or epigenetic variation were not studied and may be relevant [28]. As well, a weak association may be beyond the statistical power of the present study to detect.
###end p 38
###begin title 39
Competing interests
###end title 39
###begin p 40
The author(s) declare that they have no competing interests.
###end p 40
###begin title 41
Authors' contributions
###end title 41
###begin p 42
DWO aided in the molecular genetic studies. JDO assigned the C4 typing. ART aided in the study design and assays, coordination the research and helped to draft the manuscript. TLS conceived of the study, carried out the molecular genetic studies, participated in the design, performed the statistical analysis and drafted the manuscript. All authors have read and approved the final manuscript.
###end p 42
###begin title 43
Pre-publication history
###end title 43
###begin p 44
The pre-publication history for this paper can be accessed here:
###end p 44
###begin p 45

###end p 45
###begin title 46
Acknowledgements
###end title 46
###begin p 47
###xml 94 101 <span type="species:ncbi:9606">Persons</span>
This research project was supported with funding from The Jonty Foundation and the Center for Persons with Disabilities (Utah State University). We would like to thank Dr. Dave Ward (Nevada Cancer Institute) and Dr. Jonna Westover (CPD) for their suggestions and aid in preparing the manuscript.
###end p 47
###begin article-title 48
Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 14 sites, United States, 2002
###end article-title 48
###begin article-title 49
Infantile autism: a genetic study of 21 twin pairs
###end article-title 49
###begin article-title 50
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders
###end article-title 50
###begin article-title 51
###xml 50 55 <span type="species:ncbi:9606">human</span>
The intricate role of complement componenet C4 in human systemic lupus erythematosus
###end article-title 51
###begin article-title 52
HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation
###end article-title 52
###begin article-title 53
###xml 26 31 <span type="species:ncbi:9606">human</span>
Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module)
###end article-title 53
###begin article-title 54
###xml 16 21 <span type="species:ncbi:9606">human</span>
Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) nodules in Caucasians: the load of RCCX genetic diversity on major histocompatibility complex-associated disease
###end article-title 54
###begin article-title 55
Increased frequency of the null allele at the complement C4b locus in autism
###end article-title 55
###begin article-title 56
Immunogenetic studies in autism and related disorders
###end article-title 56
###begin article-title 57
Confirmation of the association of the C4B null allele in autism
###end article-title 57
###begin article-title 58
Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region
###end article-title 58
###begin article-title 59
###xml 20 25 <span type="species:ncbi:9606">human</span>
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes: restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants
###end article-title 59
###begin article-title 60
The autism diagnostic observation schedule: A standardized observation of communicative and social behavior
###end article-title 60
###begin article-title 61
###xml 95 102 <span type="species:ncbi:9606">persons</span>
Autism Diagnostic Interview: A semistructured interview for parents and caregivers of autistic persons
###end article-title 61
###begin article-title 62
The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder
###end article-title 62
###begin article-title 63
###xml 14 19 <span type="species:ncbi:9606">human</span>
Comprehensive human genome amplification using multiple displacement amplification
###end article-title 63
###begin article-title 64
Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene
###end article-title 64
###begin article-title 65
Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency)
###end article-title 65
###begin article-title 66
Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population
###end article-title 66
###begin article-title 67
The MHC Haplotype Project
###end article-title 67
###begin article-title 68
Complete MHC haplotype sequencing for common disease gene mapping
###end article-title 68
###begin article-title 69
Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes
###end article-title 69
###begin article-title 70
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
###end article-title 70
###begin article-title 71
Lower cortisol and higher ACTH levels in individuals with autism
###end article-title 71
###begin article-title 72
Androgenic activity in autism
###end article-title 72
###begin article-title 73
Androgens and autistic traits: A study of individuals with congenital adrenal hyperplasia
###end article-title 73
###begin article-title 74
###xml 71 79 <span type="species:ncbi:9606">children</span>
Foetal testosterone, social relationships, and restricted interests in children
###end article-title 74
###begin article-title 75
Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency
###end article-title 75

